ebook Munafa Stock Market Course + Intraday & FNO calls  

       

ZYDUSLIFE 910 PE (PUT) 27 January 2026 options price chart analysis Zydus Lifesciences Ltd

Live Options price premium & chart analysis for ZYDUSLIFE 910 PE (PUT) 27 January 2026 options price chart analysis Zydus Lifesciences Ltd

Zydus Lifesciences Ltd ZYDUSLIFE trades in NSE under NSE

ZYDUSLIFE 910 PE Live prices

What is premium price of ZYDUSLIFE 910 PE PUT today?
Premium of ZYDUSLIFE 910 PE is 18.25 on 26 Dec 2025 PUT opened at 17.75 and traded inside a Low-High range of 17.75-19.25 today. Please click here table for more current prices.
What is open interest of ZYDUSLIFE 910 PUT PE today?
Open Interest of ZYDUSLIFE 910 PE is 47700 today. This has changed 26100.00 from previous day.
What is underlying price of ZYDUSLIFE 910 PE PUT today?
Underlying price of ZYDUSLIFE 910 PE PUT is 911.55 today.
What is lot size of ZYDUSLIFE 910 PUT PE today?
Lot size of ZYDUSLIFE 910 PUT PE is 900.00
Is ZYDUSLIFE 910 PE PUT ITM or OTM or ATM?
ZYDUSLIFE 910 PUT PE is ATM PUT option (at the money). Only ITM options have intrinsic value in them, while OTM options have only time value in them.

Underlying equity prev closing: 911.55

ZYDUSLIFE PUT PE available options strikes

PE 870, PE 880, PE 890, PE 900, PE 910, PE 920, PE 930, PE 940, PE 950, All CE , All PE

ZYDUSLIFE 910 PUT PE available expiry dates

30 Dec 202527 Jan 202624 Feb 2026

Premium of ZYDUSLIFE 910 PUT PE January 27 2026

ZYDUSLIFE 910 PE Live prices

Premium of PUT (PE) of strike 910 is at: 18.25 on 26 Dec 2025
PUT opened at 17.75 and traded inside a Low-High range of 17.75-19.25 as on 26 Fri Dec 2025

The underlying equity is trading at 911.55 which means that PUT of strike 910 is ATM PUT option (at the money)

Lot size of ZYDUSLIFE Zydus Lifesciences Ltd is 900

Total Open Interest for PUT (PE) of strike 910 is 47,700

Munafa analysis ZYDUSLIFE 910 PE might prove profitable for buyers, but sellers of this PUT could lose money trading this option

Price action analysis of 910 PUT based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.

Price action analysis of 910 PUT based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.

Click here to view most profitable CE and PE for Zydus Lifesciences Ltd, both for buyers and sellers | ZYDUSLIFE Most Active Call Put Options

Date Underlying price PE price PE open PE high PE low PE volume PE OI OI Change
26 Fri Dec 911.55 18.25 17.75 19.25 17.75 19 42,930,000 120.8%
24 Wed Dec 917.80 15.25 11.30 16.35 10.95 33 19,440,000 166.7%
23 Tue Dec 927.80 11.40 12.85 12.85 10.90 -34 7,290,000 800%
22 Mon Dec 918.20 17.50 0.00 0.00 0.00 0 810,000 0%
19 Fri Dec 919.60 17.50 0.00 0.00 0.00 0 810,000 0%
18 Thu Dec 913.65 17.50 17.50 17.50 17.50 -43 810,000 -%

Charts for ZYDUSLIFE 910 PUT PE options for Zydus Lifesciences Ltd

Select an expiry and a strike price below to view charts for those options. ZYDUSLIFE All in One charts

Charts for:      

Dark shadowed line on the chart below is the current SPOT price line of underlying equity. White line on the chart is the option closing price line. Candle sticks on the chart are the OHLC for the option.

ZYDUSLIFE 910 PE (PUT) 27 January 2026 options price chart analysis Zydus Lifesciences Ltd

ZYDUSLIFE further analysis

ZYDUSLIFE 910 PE (PUT) 27 January 2026 options price chart analysis Zydus Lifesciences Ltd

These are ZYDUSLIFE 910 PE (PUT) 27 January 2026 options price chart analysis Zydus Lifesciences Ltd . Click the links below to switch between charts

 

Videos related to: ZYDUSLIFE 910 PE (PUT) 27 January 2026 options price chart analysis Zydus Lifesciences Ltd

Hindi Basics How To Trade In FnO Futures Options Stock Market

Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts

ZYDUSLIFE 910 PE (PUT) 27 January 2026 options price chart analysis Zydus Lifesciences Ltd

 

Back to top